This expertise is based on highly qualified motivated employees working in a safe and functional professional environment. This highly performing professional environment is applied from the Medical Biology Laboratory (accredited ISO 15189), the Laboratory for Environment and Food Safety and the vaccination centers to all research activities on emerging infectious diseases.
The IPC has largely improved its equipment for research and public health programs thanks to multiple grants with international research institutions/development partners, and the support from the Institut Pasteur in Paris.
The Institut Pasteur du Cambodge owns seven BLS-2 laboratories (incl. 2 BLS-2+) for handling hazardous microorganisms but not fatal for humans or for which vaccines and treatments exists such as tuberculosis, rabies, respiratory viruses classics etc. Those BLS-2 laboratories are placed in a depression zone and entrance is through an airlock. Pathogens are handled in vertical laminar flow hoods to protect the operator. In addition, since 2008, the IPC hosts a high level biosafety (BSL-3) laboratory for service and research purposes (four modules occupied for MDR and XDR-TB, H5N1 Avian flu, COVID-19), new or unknown viruses isolated from severe human cases, and one animal (ASL-3) facility for research projects on virus transmission and pathophysiology experiments. This infrastructure is unique in Cambodia and there are very few such functional laboratories in the Greater Mekong sub-region.